---
title: "Naltrexone - Obesity"
sidebar: mydoc_sidebar
permalink: db00704-mesh-d009765-1.html
toc: false 
---


Path ID: `DB00704_MESH_D009765_1`
{% include image.html url="images/db00704-mesh-d009765-1.png" file="db00704-mesh-d009765-1.png" alt="db00704-mesh-d009765-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009270 | Naltrexone | Drug |
| MESH:D009765 | Obesity | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Naltrexone | TREATS | Obesity |
|---------|-----------|---------|

Comment: Naltrexone is associated with minimal weight loss as monotherapy, but has potential utility in the treatment of obesity when combined with Pro-opiomelanocortin activator - bupropion.

Reference: [https://go.drugbank.com/drugs/DB00704#mechanism-of-action](https://go.drugbank.com/drugs/DB00704#mechanism-of-action){:target="_blank"}